G796-0295 Screening compound: 1-(6-methyl-1H-1,3-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide

G796-0295 Screening compound: 1-(6-methyl-1H-1,3-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide
G796-0295 Screening compound: 1-(6-methyl-1H-1,3-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G796-0295
1-(6-methyl-1H-1,3-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G796-0295

Molecular Formula

C27H35N5O (C27 H35 N5 O)

Compound Name

1-(6-methyl-1H-1,3-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide

IUPAC name

1-(6-methyl-1H-13-benzodiazol-2-yl)-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)piperidine-4-carboxamide

SMILES

Cc1ccc(CN2CC(CNC(C(CC3)CCN3c3nc(ccc(C)c4)c4[nH]3)=O)CC2)cc1

InChI

InChI=1S/C27H35N5O/c1-19-3-6-21(7-4-19)17-31-12-9-22(18-31)16-28-26(33)23-10-13-32(14-11-23)27-29-24-8-5-20(2)15-25(24)30-27/h3-8,15,22-23H,9-14,16-18H2,1-2H3,(H,28,33)(H,29,30)/t22-/m1/s1

InChI Key

KSOSGHVHPJEUBA-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD15036509

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.61

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.833

Distribution Coefficient, logD

0.044

Water Solubility, LogSw

-3.87

Polar Surface Area

50.354

Acid Dissociation Constant (pKa)

14.25

Base Dissociation Constant (pKb)

11.19

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.10

G796-0295 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G796-0295 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G796-0295?
Check Price and Availability of G796-0295, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G796-0295 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G796-0295
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G796-0295
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G796-0295 available by request